[1]
J. Rouanet, I. Joulie, C. Lambert, and M. D’Incan, “Real-life Use of Bexarotene for T-cell Cutaneous Lymphoma Management: Efficacy and Tolerance with Low Doses”, Acta Derm Venereol, vol. 102, p. adv00746, Jul. 2022.